Zribi, A., Al Riyami, K., Al Zahibi, H.S. and Burney, I.A. 2024. Managing the Adverse Events Associated with Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer. Sultan Qaboos University Medical Journal. 24, 2 (May 2024), 293–297. DOI:https://doi.org/10.18295/squmj.9.2023.057.